Askina Calgitrol Paste Burns

Clinical Trial Summary

The purpose of the study is to demonstrate that Askina® Calgitrol® Paste is safe to use on III degree burns by quantifying the concentration of silver in the blood during treatment and thus to show that the amount of silver absorbed will be no greater than those reported in the literature.

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT01715012` - Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts	Phase 2
	Completed	`NCT02285517` - Comparing Modified Meek and Mesh Techniques	N/A

See also

Status

Clinical Trial

Phase

Terminated

NCT01715012 - Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

Phase 2

Completed

NCT02285517 - Comparing Modified Meek and Mesh Techniques

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01911858
Study type	Interventional
Source	BBraun Medical SAS
Contact
Status	Withdrawn
Phase	Phase 3
Start date	April 2013

Askina Calgitrol Paste Burns

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms